000 | 01692 a2200469 4500 | ||
---|---|---|---|
005 | 20250516174352.0 | ||
264 | 0 | _c20140929 | |
008 | 201409s 0 0 eng d | ||
022 | _a1438-8782 | ||
024 | 7 |
_a10.1055/s-0033-1355834 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalvatore, V | |
245 | 0 | 0 |
_aEarly prediction of treatment response to sorafenib with elastosonography in a mice xenograft model of hepatocellular carcinoma: a proof-of-concept study. _h[electronic resource] |
260 |
_bUltraschall in der Medizin (Stuttgart, Germany : 1980) _cDec 2013 |
||
300 |
_a541-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aElasticity Imaging Techniques |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHeterografts |
650 | 0 | 4 |
_aLiver _xdiagnostic imaging |
650 | 0 | 4 |
_aLiver Neoplasms, Experimental _xdiagnostic imaging |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
650 | 0 | 4 | _aSorafenib |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
700 | 1 | _aBaron Toaldo, M | |
700 | 1 | _aMarinelli, S | |
700 | 1 | _aMilazzo, M | |
700 | 1 | _aPalamà , C | |
700 | 1 | _aVenerandi, L | |
700 | 1 | _aCipone, M | |
700 | 1 | _aBolondi, L | |
700 | 1 | _aPiscaglia, F | |
773 | 0 |
_tUltraschall in der Medizin (Stuttgart, Germany : 1980) _gvol. 34 _gno. 6 _gp. 541-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1355834 _zAvailable from publisher's website |
999 |
_c23177753 _d23177753 |